Related Experiment Video
Updated: Jan 9, 2026

An Improved Method for Collection of Cerebrospinal Fluid from Anesthetized Mice
Published on: March 19, 2018
Comparing antibody and small-molecule therapies for cancer
1Sapporo Medical University, South 1, West 17, Chuo-ku, Sapporo, 060-8556, Japan. imai@sapmed.ac.jp
Abstract:
The 'magic bullet' concept of specifically targeting cancer cells at the same time as sparing normal tissues is now proven, as several monoclonal antibodies and targeted small-molecule compounds have been approved for cancer treatment. Both antibodies and small-molecule compounds are therefore promising tools for target-protein-based cancer therapy. We discuss and compare the distinctive properties of these two therapeutic strategies so as to provide a better view for the development of new drugs and the future direction of cancer therapy.
Insights
Targeted cancer therapies, including monoclonal antibodies and small-molecule compounds, effectively target cancer cells while sparing normal tissues. This review compares these strategies to guide future cancer drug development.
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- The 'magic bullet' concept aims to selectively target cancer cells, sparing healthy tissues.
- Monoclonal antibodies and small-molecule compounds represent successful targeted therapies in oncology.
- These agents offer promising avenues for protein-targeted cancer treatment.
Purpose of the Study:
- To discuss and compare monoclonal antibodies and small-molecule compounds for cancer therapy.
- To provide insights into the distinctive properties of these two therapeutic strategies.
- To guide the development of novel cancer drugs and future therapeutic directions.
Main Methods:
- Literature review and comparative analysis of existing therapeutic strategies.
- Discussion of target-protein-based cancer therapy mechanisms.
- Synthesis of information on antibody and small-molecule compound properties.
Main Results:
- Both monoclonal antibodies and small-molecule compounds have proven effective in clinical cancer treatment.
- These targeted agents demonstrate the feasibility of the 'magic bullet' approach.
- Distinctive properties of each strategy offer unique advantages and considerations.
Conclusions:
- Monoclonal antibodies and small-molecule compounds are valuable tools for target-protein-based cancer therapy.
- Comparative understanding of these agents is crucial for advancing cancer drug development.
- Future cancer therapy will likely involve refined application and combination of these targeted strategies.
Related Concept Videos
06:40An Improved Method for Collection of Cerebrospinal Fluid from Anesthetized Mice
08:40Absolute Quantification of Aβ1-42 in CSF Using a Mass Spectrometric Reference Measurement Procedure
11:47Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function
05:51Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
11:56A Rapid and Specific Microplate Assay for the Determination of Intra- and Extracellular Ascorbate in Cultured Cells
14:55Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System

